![Geert Jan van Daal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 90 815 $ al 30/06/2026
Geert Jan van Daal was Chief Commercial Officer at Santhera Pharmaceuticals Holding AG from 2024 to 2026.
Dr. van Daal earned a doctorate from Erasmus University Rotterdam.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2024 | 4.666 ( 0,03 % ) | 90 815 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01/06/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
Elige MarketScreener 
